MEDIF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
19.13M
NPPNY
Price
$5.34
Change
+$0.13 (+2.50%)
Updated
Jul 31 closing price
Capitalization
2.75B
Interact to see
Advertisement

MEDIF vs NPPNY

Header iconMEDIF vs NPPNY Comparison
Open Charts MEDIF vs NPPNYBanner chart's image
Medipharm Labs
Price$0.05
Change-$0.00 (-0.00%)
Volume$5.73K
Capitalization19.13M
Nippon Shinyaku
Price$5.34
Change+$0.13 (+2.50%)
Volume$216
Capitalization2.75B
MEDIF vs NPPNY Comparison Chart in %
Loading...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPPNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEDIF vs. NPPNY commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDIF is a Hold and NPPNY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (MEDIF: $0.05 vs. NPPNY: $5.34)
Brand notoriety: MEDIF and NPPNY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MEDIF: 17% vs. NPPNY: 7%
Market capitalization -- MEDIF: $19.13M vs. NPPNY: $2.75B
MEDIF [@Pharmaceuticals: Other] is valued at $19.13M. NPPNY’s [@Pharmaceuticals: Other] market capitalization is $2.75B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEDIF’s FA Score shows that 0 FA rating(s) are green whileNPPNY’s FA Score has 2 green FA rating(s).

  • MEDIF’s FA Score: 0 green, 5 red.
  • NPPNY’s FA Score: 2 green, 3 red.
According to our system of comparison, NPPNY is a better buy in the long-term than MEDIF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEDIF’s TA Score shows that 3 TA indicator(s) are bullish while NPPNY’s TA Score has 5 bullish TA indicator(s).

  • MEDIF’s TA Score: 3 bullish, 2 bearish.
  • NPPNY’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, NPPNY is a better buy in the short-term than MEDIF.

Price Growth

MEDIF (@Pharmaceuticals: Other) experienced а +4.29% price change this week, while NPPNY (@Pharmaceuticals: Other) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.

Industries' Descriptions

@Pharmaceuticals: Other (+3.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NPPNY($2.75B) has a higher market cap than MEDIF($19.1M). MEDIF YTD gains are higher at: 29.540 vs. NPPNY (-19.503). NPPNY has higher annual earnings (EBITDA): 36B vs. MEDIF (-41.42M). NPPNY has more cash in the bank: 64.4B vs. MEDIF (20.2M). MEDIF has less debt than NPPNY: MEDIF (218K) vs NPPNY (2.11B). NPPNY has higher revenues than MEDIF: NPPNY (141B) vs MEDIF (22.2M).
MEDIFNPPNYMEDIF / NPPNY
Capitalization19.1M2.75B1%
EBITDA-41.42M36B-0%
Gain YTD29.540-19.503-151%
P/E RatioN/A16.53-
Revenue22.2M141B0%
Total Cash20.2M64.4B0%
Total Debt218K2.11B0%
FUNDAMENTALS RATINGS
MEDIF vs NPPNY: Fundamental Ratings
MEDIF
NPPNY
OUTLOOK RATING
1..100
830
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9517
PRICE GROWTH RATING
1..100
5877
P/E GROWTH RATING
1..100
10082
SEASONALITY SCORE
1..100
503

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NPPNY's Valuation (9) in the null industry is significantly better than the same rating for MEDIF (89). This means that NPPNY’s stock grew significantly faster than MEDIF’s over the last 12 months.

NPPNY's Profit vs Risk Rating (100) in the null industry is in the same range as MEDIF (100). This means that NPPNY’s stock grew similarly to MEDIF’s over the last 12 months.

NPPNY's SMR Rating (17) in the null industry is significantly better than the same rating for MEDIF (95). This means that NPPNY’s stock grew significantly faster than MEDIF’s over the last 12 months.

MEDIF's Price Growth Rating (58) in the null industry is in the same range as NPPNY (77). This means that MEDIF’s stock grew similarly to NPPNY’s over the last 12 months.

NPPNY's P/E Growth Rating (82) in the null industry is in the same range as MEDIF (100). This means that NPPNY’s stock grew similarly to MEDIF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDIFNPPNY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
45%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
30%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
25%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 29 days ago
40%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
48%
Aroon
ODDS (%)
N/A
Bearish Trend 7 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPPNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADBKF25.75N/A
N/A
ADDIKO BK AG
NCTKF15.81N/A
N/A
Nabtesco Corp.
SCVPY4.90N/A
N/A
Siam Cement Public Co. Ltd.
CWID1.10N/A
N/A
Country-Wide Insurance Co.
ECRFF0.11N/A
-0.45%
Cartier Resources, Inc.

NPPNY and

Correlation & Price change

A.I.dvisor tells us that NPPNY and MEDIF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
N/A
MEDIF - NPPNY
11%
Poorly correlated
-1.74%
OVATF - NPPNY
10%
Poorly correlated
N/A
OMID - NPPNY
3%
Poorly correlated
N/A
MGWFF - NPPNY
0%
Poorly correlated
-0.85%
OILFF - NPPNY
-1%
Poorly correlated
N/A
More